ArticleOncotarget2017
Roflumilast restores cAMP/PKA/CREB signaling axis for FtMt-mediated tumor inhibition of ovarian cancer.
Shipeng Gong et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
23 papers cite it
this papercites it
ArticleOncotarget2017
Shipeng Gong et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.